New England Has $9 Billion Worth of Reasons to Embrace the Pharmaceutical-Biotech Industry, an Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwired) -- 07/24/13 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- North America has nearly 1,300 active Pharmaceutical-Biotech capital and maintenance projects with a total investment value (TIV) of $57 billion. According to a recent analysis of Industrial Info's database, the region reigns in the top spot with a $9 billion slice of that spending.
Other companies featured: (NASDAQ:VRTX), (NYSE:NVS)
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at , or browse other breaking industrial news stories at .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
Joe Govreau
713-783-5147
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 24.07.2013 - 10:15 Uhr
Sprache: Deutsch
News-ID 281231
Anzahl Zeichen: 0
contact information:
Town:
SUGAR LAND, TX
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 207 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"New England Has $9 Billion Worth of Reasons to Embrace the Pharmaceutical-Biotech Industry, an Industrial Info News Alert"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
